[1]
O. Rakhmatov, “EVALUATION OF CHANGES IN INTERLEUKIN-4 LEVELS WHEN USING THE IMMUNOMODULATOR GEPON IN THE TREATMENT OF PATIENTS WITH CUTANEOUS LEISHMANIASIS”, RAE, vol. 2, no. 5, pp. 269–278, May 2023.